Cyclo Therapeutics
Why Robinhood?
You can watch CYTH and buy or sell other stocks, ETFs, and their options commission-free!About CYTH
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease.
CYTH Key Statistics
Stock Snapshot
As of today, Cyclo Therapeutics(CYTH) shares are valued at $0.72. The company's market cap stands at 23.72M, with a P/E ratio of -0.81.
On 2026-03-10, Cyclo Therapeutics(CYTH) stock opened at —, reached a high of —, and a low of —.
The Cyclo Therapeutics(CYTH)'s current trading volume is 0, compared to an average daily volume of 22.85K.
During the past year, Cyclo Therapeutics(CYTH) stock moved between $0.55 at its lowest and $1.62 at its peak.
During the past year, Cyclo Therapeutics(CYTH) stock moved between $0.55 at its lowest and $1.62 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.